User profiles for "author:Parikh P"

Purvish M Parikh - Verified email at purvishparikh.com - Cited by 13311
Prof Priti Parikh - Verified email at ucl.ac.uk - Cited by 4057
Puja Parikh - Verified email at stonybrookmedicine.edu - Cited by 2454

Lung cancer immunotherapy: progress, pitfalls, and promises

A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …

AlGaN/GaN HEMTs-an overview of device operation and applications

UK Mishra, P Parikh, YF Wu - Proceedings of the IEEE, 2002 - ieeexplore.ieee.org
Wide bandgap semiconductors are extremely attractive for the gamut of power electronics
applications from power conditioning to microwave transmitters for communications and …

Diabetic cardiomyopathy: the search for a unifying hypothesis

IG Poornima, P Parikh, RP Shannon - Circulation research, 2006 - ahajournals.org
Although diabetes is recognized as a potent and prevalent risk factor for ischemic heart
disease, less is known as to whether diabetes causes an altered cardiac phenotype …

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non–small-cell lung cancer

GV Scagliotti, P Parikh, J Von Pawel… - Journal of clinical …, 2008 - ascopubs.org
Purpose Cisplatin plus gemcitabine is a standard regimen for first-line treatment of
advanced non–small-cell lung cancer (NSCLC). Phase II studies of pemetrexed plus …

A unified correlation for estimating HHV of solid, liquid and gaseous fuels

SA Channiwala, PP Parikh - Fuel, 2002 - Elsevier
A unified correlation for computation of higher heating value (HHV) from elemental analysis
of fuels is proposed in this paper. This correlation has been derived using 225 data points …

30-W/mm GaN HEMTs by field plate optimization

YF Wu, A Saxler, M Moore, RP Smith… - IEEE Electron …, 2004 - ieeexplore.ieee.org
GaN high-electron-mobility-transistors (HEMTs) on SiC were fabricated with field plates of
various dimensions for optimum performance. Great enhancement in radio frequency (RF) …

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled …

N Thatcher, A Chang, P Parikh, JR Pereira, T Ciuleanu… - The Lancet, 2005 - thelancet.com
Background This placebo-controlled phase III study investigated the effect on survival of
gefitinib as second-line or third-line treatment for patients with locally advanced or metastatic …

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non–small-cell lung cancer

FR Hirsch, M Varella-Garcia, PA Bunn Jr… - Journal of clinical …, 2006 - ascopubs.org
Purpose The phase III Iressa Survival Evaluation in Lung Cancer (ISEL) trial compared
gefitinib with placebo in 1,692 patients with refractory advanced non–small-cell lung cancer …

Very-high power density algan/gan hemts

YF Wu, D Kapolnek, JP Ibbetson… - … on Electron Devices, 2001 - ieeexplore.ieee.org
Research work focusing on the enhancement of large-signal current-voltage (IV) capabilities
has resulted in significant performance improvement for AlGaN/GaN HEMT's. 100-150/spl …

Mapping synergies and trade-offs between energy and the Sustainable Development Goals

F Fuso Nerini, J Tomei, LS To, I Bisaga, P Parikh… - Nature Energy, 2018 - nature.com
Abstract The 2030 Agenda for Sustainable Development—including 17 interconnected
Sustainable Development Goals (SDGs) and 169 targets—is a global plan of action for …